Jack A. Clark

Jack A. Clark

Auto-generated profile, based on publicly available information

Jack A. Clark

Boston University School of Public Health

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 1998 in Archives of internal medicine (1960)
Verified
Journal Article
Open access
PDF file
LKLewis Kazis
Lewis Kazis
DMDonald R. Miller
Donald R. Miller
JCJack Clark
Jack Clark
KSKatherine Skinner
Katherine Skinner
ALAustin Lee
Austin Lee
MLMark Linzer
Mark Linzer
THE DEPARTMENT of Veterans Affairs Health Care System (VA) is a federally funded integrated system of care, with about 5% of the total market share for hospital services.1 It serves a select group of veterans, with complex health care needs. Compared with veterans nationally and the general US population, users of the VA health care system not only have disabilities that are connected to their military service but they are also older, poorer, less educated, and sicker with more disease.2,3 Lessons learned from the VA can provide a model for monitoring the outcomes of care in other managed care systems, especially those serving older populations. Like other health care systems that are seeking to adapt to a changing health care environment, the VA needs information about the health of current and prospective patients to anticipate patient demand, design effective services, and evaluate the outcomes of its care. The information that the VA has at hand to guide providers of care, administrators, and policymakers regarding ambulatory care is limited. In response to these needs, the Veterans Health Study (VHS) was developed to implement and demonstrate the use of monitoring patient-derived measures of functional status in the VA.

1 January 1998 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
JTJ A Talcott
J A Talcott
PRP Rieker
P Rieker
JCJ A Clark
J A Clark
KPK J Propert
K J Propert
JWJ C Weeks
J C Weeks
PKP W Kantoff
P W Kantoff
PURPOSE: To assess complications of therapy for early (nonmetastatic) prostate cancer. PATIENTS AND METHODS: A prospective study of a cohort of 279 men who sought treatment advice and completed required pretreatment forms. The measures were self-reported patient symptoms and other measures of quality of life before therapy and at 3 and 12 months afterward. RESULTS: Bowel and bladder symptoms were uncommon pretreatment. Patients frequently reported irritative bowel and bladder symptoms at 3 months after radiotherapy, although these subsided somewhat at 12 months. Substantial ("a lot") urinary incontinence and wearing of absorptive pads were reported by 11% and 35% at 12 months after surgery and varied little by age. Incontinence occurred after radiotherapy infrequently, and only in men more than 65 years old. Inadequate erections, present in one third of men pretreatment, were nearly universal at 3 months after surgery, although some improvement, primarily in men under 65 years of age, was evident at 12 months. Sexual dysfunction after radiotherapy increased less but continually through 12 months, suggesting that observed treatment-related differences would decline with further follow-up. CONCLUSION: External-beam radiotherapy of early prostate cancer is followed by bowel and bladder irritability, by increasingly severe sexual dysfunction and, in men aged more than 65 years, occasional urinary incontinence. Greater sexual dysfunction and urinary incontinence occur in the year following radical prostatectomy. These postsurgical complication rates from patient questionnaires are greater than have been reported in other treatment series and confirm the results of two retrospective studies of patient-reported complications.

1 January 1999 in American Journal of Medical Quality
Verified
Journal Article
Closed access
LKLewis Kazis
Lewis Kazis
XRXinhua S. Ren
Xinhua S. Ren
ALAustin Lee
Austin Lee
KSKatherine Skinner
Katherine Skinner
WRWilliam Rogers
William Rogers
DMDonald R. Miller
Donald R. Miller
Recently, the Veterans Administration (VA) Under Secretary for Health has designated functional status as one of the domains of value for the system, given its increasing importance for clinical care. The Veterans Health Study (VHS) was designed to assist the VA in monitoring outcomes and measuring the case mix of patients who use the VA. The Veterans SF-36 (short form functional status assessment for veterans) was administered to 2425 veterans receiving ambulatory care. Measures of the Veterans SF-36 were strongly correlated with sociodemographics and morbidities of the veterans. Young veterans had poorer mental health status than older veterans. Veterans who used ambulatory care in the VHS reported lower levels of health status, reflecting more disease than a non-VA civilian population. These measures of health are important indicators of the disease burden or case mix of the patients and are pertinent to health systems such as the VA for resource allocation decisions and as outcomes of care.

6 August 1997 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
JTJames A. Talcott
James A. Talcott
PRPatricia Rieker
Patricia Rieker
KPKathleen J. Propert
Kathleen J. Propert
JCJack A. Clark
Jack A. Clark
PKPhilip W. Kantoff
Philip W. Kantoff
JRJerome P. Richie
Jerome P. Richie
Background: The age-adjusted rate of radical prostatectomy, the most common treatment of early (nonmetastatic) prostate cancer, increased almost sixfold between 1984 and 1990. This increase was due in part to reported improvements in postoperative sexual potency after the use of newly developed “nerve-sparing” procedures. However, published estimates from physicians of impotence following various types of radical prostatectomy may be low, since not all patients may report treatment-related complications accurately and completely to their doctors. In contrast, direct surveys of patients indicate much higher rates of postoperative sexual and urinary dysfunction. One problem with most physician and patient surveys is that they have been performed retrospectively, and pretreatment impotence and incontinence prevalent in older men cannot be assessed accurately in retrospective studies. Purpose: This study was initiated in a cohort of men before they underwent radical prostatectomy to assess treatment-related effects on impotence and incontinence. Methods: The study population consisted of 94 men enrolled in a cohort study of treatment for early prostate cancer. The patients completed questionnaires about sexual and urinary functions before surgery and at 3 and 12 months after surgery and had adequate information to assess the type of surgical technique used (non-nerve-sparing, unilateral nerve-sparing, or bilateral nerve-sparing). Because items assessing sexual function were inadvertently omitted from the questionnaire in the initial months of the study, information on sexual function for all time periods was available for only 49 men. Results: Compared with men who had not been treated with a nerve-sparing procedure, men who underwent nerve-sparing radical prostatectomy, particularly of the bilateral type, were younger and had better prognostic features, indicating less advanced cancers. Before surgery, nine (75%) of 12 men not treated with a nerve-sparing procedure reported erections that were usually inadequate for sexual intercourse compared with six (33%) of 18 men and one (5%) of 19 men who underwent unilateral and bilateral nerve-sparing prostatectomies, respectively. At 12 months after surgery, most men reported inadequate erections, including 15 (79%) of the 19 men who had bilateral nerve-sparing surgery; unilateral nerve preservation provided no apparent benefit. In general, nerve-sparing surgery was associated with more use of absorbent pads at 3 and 12 months following treatment, and this approach was associated with substantial urinary incontinence at 3 months but not at 12 months following surgery. Conclusions: Nervesparing prostatectomy, particularly when performed unilaterally, improves postoperative sexual function to a lesser extent than previously reported. Because men with preoperative impotence and more advanced cancers receive nervesparing surgery less often, some of the previously reported benefit of nerve preservation may be the result of patient selection and not of the technique per se.

1 November 2003 in Journal of Urology
Verified
Journal Article
Closed access
AZAnthony L. Zietman
Anthony L. Zietman
DSDianne Sacco
Dianne Sacco
USUri Skowronski
Uri Skowronski
PGPablo Gomery
Pablo Gomery
DKDonald S. Kaufman
Donald S. Kaufman
WSWilliam U. Shipley
William U. Shipley
Purpose: Transurethral resection, chemotherapy and radiation with salvage cystectomy may be used as alternatives to immediate radical cystectomy in the management of invasive bladder cancer...

1 January 2001 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
JCJack A. Clark
Jack A. Clark
NWNelda P. Wray
Nelda P. Wray
CACarol M. Ashton
Carol M. Ashton
PURPOSE: To examine variation in men’s long-term regret of treatment decisions, ie, surgical versus chemical castration, for metastatic prostate cancer and its associations with quality of life. METHODS: Survey of previously treated patients to assess treatment decisions and quality of life, supplemented with focus groups. Two items addressing whether a patient wished he could change his mind and the belief that he would have been better off with the treatment not chosen were combined in classifying survey respondents as either satisfied or regretful. χ2 and t tests were used to test associations between regret and treatment history, complications, and quality of life. RESULTS: Survey respondents included 201 men aged 45 to 93 years (median, 71 years), who had begun treatment (71% chemical castration, 29% orchiectomy) a median of 2 years previously. Most reported complications: hot flashes (70%), nausea (34%), and erectile dysfunction (81%). Most were satisfied with the treatment decision, but 23% expressed regret. Regretful men more frequently reported surgical (43%) versus chemical (36%) castration (P = .030) and nausea in the past week (54% v 32%; P = .010) but less frequently reported erectile dysfunction (56% v 72%; P = .048). Regretful men indicated poorer scores on every measure of generic and prostate cancer–related quality of life. Qualitative analyses revealed substantial uncertainty about the progress of their disease and the quality of the decisions in which patients participated. CONCLUSION: Regret was substantial and associated with treatment choice and quality of life. It may derive from underlying psychosocial distress and problematic communication with physicians when decisions are being reached and over subsequent years.